The implementation and acceptability of an HPV vaccination decision support system directed at both clinicians and families
- PMID: 23304334
- PMCID: PMC3540460
The implementation and acceptability of an HPV vaccination decision support system directed at both clinicians and families
Abstract
We developed an electronic medical record (EMR)-based HPV vaccine decision support intervention targeting clinicians, (immunization alerts, education, and feedback) and families (phone reminders and referral to an educational website). Through telephone surveys completed by 162 parents of adolescent girls, we assessed the acceptability of the family-focused intervention and its effect on information-seeking behavior, communication, and HPV vaccine decision-making. The intervention was acceptable to parents and 46% remembered receiving the reminder call. Parents reported that the call prompted them to seek out information regarding the HPV vaccine, discuss the vaccine with friends and family, and reach a decision. Parents whose adolescent girls attended practices receiving the clinician-focused intervention were more likely to report that their clinician discussed the HPV vaccine at preventive visits. The results of this study demonstrate the acceptability and potential impact on clinical care of a comprehensive decision support system directed at both clinicians and families.
Figures
Similar articles
-
Effectiveness of decision support for families, clinicians, or both on HPV vaccine receipt.Pediatrics. 2013 Jun;131(6):1114-24. doi: 10.1542/peds.2012-3122. Epub 2013 May 6. Pediatrics. 2013. PMID: 23650297 Free PMC article. Clinical Trial.
-
Effect of decision support on missed opportunities for human papillomavirus vaccination.Am J Prev Med. 2014 Dec;47(6):734-44. doi: 10.1016/j.amepre.2014.08.010. Epub 2014 Nov 18. Am J Prev Med. 2014. PMID: 25455116 Free PMC article. Clinical Trial.
-
Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents.BMC Public Health. 2015 Dec 18;15:1257. doi: 10.1186/s12889-015-2579-3. BMC Public Health. 2015. PMID: 26684658 Free PMC article.
-
Improving adolescent health: focus on HPV vaccine acceptance.J Adolesc Health. 2005 Dec;37(6 Suppl):S17-23. doi: 10.1016/j.jadohealth.2005.09.010. J Adolesc Health. 2005. PMID: 16310137 Review.
-
Utilizing health information technology to improve vaccine communication and coverage.Hum Vaccin Immunother. 2013 Aug;9(8):1802-11. doi: 10.4161/hv.25031. Epub 2013 Jun 4. Hum Vaccin Immunother. 2013. PMID: 23807361 Free PMC article. Review.
Cited by
-
Behavioral interventions for vaccination uptake: A systematic review and meta-analysis.Health Policy. 2023 Nov;137:104894. doi: 10.1016/j.healthpol.2023.104894. Epub 2023 Sep 4. Health Policy. 2023. PMID: 37714082 Free PMC article. Review.
-
Overcoming Vaccine Hesitancy for Future COVID-19 and HIV Vaccines: Lessons from Measles and HPV Vaccines.Curr HIV/AIDS Rep. 2022 Oct;19(5):328-343. doi: 10.1007/s11904-022-00622-0. Epub 2022 Sep 17. Curr HIV/AIDS Rep. 2022. PMID: 36114951 Free PMC article. Review.
-
Provider perspectives on multilevel barriers to HPV vaccination.Hum Vaccin Immunother. 2019;15(7-8):1784-1793. doi: 10.1080/21645515.2019.1581554. Epub 2019 Apr 11. Hum Vaccin Immunother. 2019. PMID: 30779687 Free PMC article.
-
An environmental scan to examine stakeholder perspectives on human papillomavirus vaccination: A mixed methods study.Vaccine. 2019 Jan 3;37(1):187-194. doi: 10.1016/j.vaccine.2018.06.073. Epub 2018 Jul 5. Vaccine. 2019. PMID: 29983257 Free PMC article.
-
User-Centered Design for Developing Interventions to Improve Clinician Recommendation of Human Papillomavirus Vaccination.Perm J. 2017;21:16-191. doi: 10.7812/TPP/16-191. Perm J. 2017. PMID: 28898195 Free PMC article.
References
-
- Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2007;56(RR-2):1–24. - PubMed
-
- Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet. 2007;369(9574):1693–1702. - PubMed
-
- Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007;369(9580):2161–2170. - PubMed
-
- Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005;6(5):271–278. - PubMed
-
- National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010. MMWR Morb Mortal Wkly Rep. 60(33):1117–1123. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous